2014
DOI: 10.1016/j.bmc.2014.04.046
|View full text |Cite
|
Sign up to set email alerts
|

Amino derivatives of glycyrrhetinic acid as potential inhibitors of cholinesterases

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
33
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
9

Relationship

3
6

Authors

Journals

citations
Cited by 52 publications
(34 citation statements)
references
References 39 publications
1
33
0
Order By: Relevance
“…Their absolute configuration at C-3 was deduced from their 1 H NMR spectra [coupling constant H-C (2)-H-C (3) and 2D-NOESY-NMR] as well as previous data reported in literature [26][27][28][29] . This reduction was not completely stereo-selective, but the epimers of opposite configuration at C-3 were only formed in minor amounts and could not be isolated [30][31][32][33][34] .…”
Section: Resultsmentioning
confidence: 91%
“…Their absolute configuration at C-3 was deduced from their 1 H NMR spectra [coupling constant H-C (2)-H-C (3) and 2D-NOESY-NMR] as well as previous data reported in literature [26][27][28][29] . This reduction was not completely stereo-selective, but the epimers of opposite configuration at C-3 were only formed in minor amounts and could not be isolated [30][31][32][33][34] .…”
Section: Resultsmentioning
confidence: 91%
“…Note that there are some published precedents where DCC-catalyzed esterification or amidation reactions stopped at the stage of intermediate product formation [20,21].…”
Section: Methodsmentioning
confidence: 99%
“…Both enzymes are widely distributed throughout the body; however, AChE remains the major cholinesterase within the human brain. BChE does not possess the same affinity for ACh as AChE does [1,2].…”
Section: Introductionmentioning
confidence: 91%
“…During the progress of AD, BChE activity is increased. Drugs which have been introduced into the treatment of AD are nonselective (rivastigmine) or AChE-selective inhibitors (galantamine or donepezil) [1,5]. In addition to the increased level of ACh, recent findings indicate that cholinesterase inhibitors can attenuate neuronal damage and protect them from cellular death, and therefore might affect AD pathogenesis and delay the progression.…”
Section: Introductionmentioning
confidence: 99%